Literature DB >> 34800152

Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus-a case report.

Lazar Tosic1, Stefanos Voglis2, Anna Maria Reuss3, Elisabeth Jane Rushing3, Luca Regli2, Carlo Serra2.   

Abstract

A nuclear protein of testis (NUT) carcinoma, also known as NUT midline carcinoma, is a rare subtype of squamous carcinoma known for its aggressive growth behaviour. It can form anywhere in the body. Although, it usually occurs along midline structures (head, neck, lungs). The authors present the first report of intrasellar NUT carcinoma with cavernous sinus infiltration in a 47-year-old patient. MRI showed an inhomogeneous, gadolinium-enhancing lesion with intra- and suprasellar growth, invasion of the cavernous sinus without clear differentiation from normal pituitary tissue. Given the lymphoma diagnosis in the frozen section and invasion of the cavernous sinus, the patient underwent endoscopic, transnasal, and transsphenoidal subtotal resection only. Local tumour and spinal metastases showed a good response to radio-chemotherapy. Despite combined radio-chemotherapy, the patient died of pulmonary insufficiency due to rapid progression of pulmonary metastasis 6 months after the initial diagnosis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Intrasellar tumour; NUT carcinoma

Mesh:

Substances:

Year:  2021        PMID: 34800152     DOI: 10.1007/s00701-021-05065-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

Review 1.  Pathogenesis of NUT midline carcinoma.

Authors:  Christopher A French
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

Review 2.  NUT midline carcinoma of the larynx: an international series and review of the literature.

Authors:  Henrik Hellquist; Christopher A French; Justin A Bishop; Andrés Coca-Pelaz; Evan J Propst; António Paiva Correia; Bo-Yee Ngan; Ronald Grant; Nicole A Cipriani; David Vokes; Rui Henrique; Fernando Pardal; Jose Ramon Vizcaino; Alessandra Rinaldo; Alfio Ferlito
Journal:  Histopathology       Date:  2017-02-21       Impact factor: 5.087

3.  Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Authors:  Daniel E Bauer; Chelsey M Mitchell; Kelly M Strait; Christopher S Lathan; Edward B Stelow; Sonja C Lüer; Somala Muhammed; Andrew G Evans; Lynette M Sholl; Juan Rosai; Eugenia Giraldi; Richard P Oakley; Carlos Rodriguez-Galindo; Wendy B London; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

4.  Histone deacetylase inhibitor for NUT midline carcinoma.

Authors:  Ossama M Maher; Anthony M Christensen; Sireesha Yedururi; Diana Bell; Nidale Tarek
Journal:  Pediatr Blood Cancer       Date:  2015-01-03       Impact factor: 3.167

5.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Authors:  Nicole G Chau; Shelley Hurwitz; Chelsey M Mitchell; Alexandra Aserlind; Noam Grunfeld; Leah Kaplan; Peter Hsi; Daniel E Bauer; Christopher S Lathan; Carlos Rodriguez-Galindo; Roy B Tishler; Robert I Haddad; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Cancer       Date:  2016-08-10       Impact factor: 6.860

Review 6.  Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature.

Authors:  Jerzy Klijanienko; Christophe Le Tourneau; José Rodriguez; Martial Caly; Stamatios Theocharis
Journal:  Diagn Cytopathol       Date:  2016-06-24       Impact factor: 1.582

7.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

Review 8.  NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.

Authors:  Christopher A French
Journal:  Pathol Int       Date:  2018-10-26       Impact factor: 2.534

9.  Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.

Authors:  Jens Engleson; Maria Soller; Ioannis Panagopoulos; Anna Dahlén; Michael Dictor; Mats Jerkeman
Journal:  BMC Cancer       Date:  2006-03-16       Impact factor: 4.430

Review 10.  NUT midline carcinoma of the head and neck: current perspectives.

Authors:  M Napolitano; M Venturelli; E Molinaro; A Toss
Journal:  Onco Targets Ther       Date:  2019-04-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.